News

Omnitrope, which is produced by Novartis' generics division Sandoz, is a copycat version of Pfizer's biotechnology product Genotropin. The approval marks the first time a biogeneric drug has

Pfizer revealed in February that it was considering the sale of its consumer healthcare operations. Although the unit generated sales of almost $4 billion last year, Pfizer stated

The decision came after the FDA examined data from a clinical trial into gender-specific lung cancer. The US-based biopharmaceutical company announced that the FDA had agreed on a

Under the terms of the agreement CFFT, the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, will award CombinatoRx up to $13.8 million in research

Vical announced that in the clinical trial, a West Nile virus (WNV) vaccine candidate administered using Vical’s proprietary DNA delivery technology was safe and well tolerated. It produced

HoFH is a rare genetic disorder that results in extremely high cholesterol. Patients with this disease display signs of high cholesterol early in life and may experience heart

This pivotal US study will enroll 360 patients with moderate-to-severe postoperative pain following abdominal surgery. A second study in a different postoperative pain model (orthopedic surgery) is planned

The Boston-based biopharmaceutical company claims Talabostat’s dual mechanism of action and positive results from the phase II study were the key components of the application for fast track

Evoltra has been granted orphan drug designation, providing marketing exclusivity for 10 years in Europe following this approval and can now be marketed throughout all 25 member states